GUDIDData
eudamed_udi Primary ID: 06970150908911

HGH CLIA Microparticles (UDI 06970150908911)

Manufactured by Autobio Diagnostics Co., Ltd.

Data verified against official FDA/EUDAMED records on
Scannable UDI-DI Representation
GS1-128 UDI Barcode representation for HGH CLIA Microparticles - Primary ID 06970150908911

Device Regulatory Overview

The HGH CLIA Microparticles (Model/Catalog Number: CML0202) is a medical device manufactured by Autobio Diagnostics Co., Ltd.. This product is indexed under FDA Product Code / Category Classification W0102060402 within international Unique Device Identification (UDI) compliance databases.

Technical Specifications

Model Number
CML0202
Product Code / EMDN
W0102060402
Device Name
AutoLumo Analyzer
Database Sync Date
2026-08-09 16:29:15

Full Regulatory Attributes

🔒 Token Gated
{
    "review_panel": "AN",
    "gudid_di_status": "Published",
    "sterilization_methods": ["EO", "Gamma"],
    "rx_only": true
}
                            

Unlock Compliance Data & Serialization Specs

Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.

Get API Token Access ($49/mo)

Frequently Asked Questions

Who is the primary manufacturer of HGH CLIA Microparticles?

The registered manufacturer of record for HGH CLIA Microparticles is Autobio Diagnostics Co., Ltd..

What is the Primary UDI-DI identifier for HGH CLIA Microparticles?

The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is 06970150908911.

What classification code is assigned to this device?

This device is registered under product classification code W0102060402.

Programmatic Export

Export this master device record as standardized JSON or CSV for compliance audits.

JSON API Endpoint